Guarneri (Iov), 'combo capivasertib-fulvestrant dimezza rischio progressione cancro seno metastatico'
2:37
Guarneri (Iov), 'combo capivasertib-fulvestrant dimezza rischio progressione cancro seno metastatico'
4 months ago
MSNAdnkronos
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Breast Cancer
1:22
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Breast Cancer
548 viewsMar 8, 2020
YouTubeOncLive
Dr Brufsky on the FDA Approval of Capivasertib Plus Fulvestrant in PIK3CA/AKT1/PTEN-Altered HR /HER2– Breast Cancer | OncLive
Dr Brufsky on the FDA Approval of Capivasertib Plus Fulvestrant in PIK3CA/AKT1/PTEN-Altered HR /HER2– Breast Cancer | OncLive
Dec 19, 2023
onclive.com
Capivasertib and Fulvestrant for Patients with Aromatase Inhibitor-resistant Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Results from the Phase III CAPItello-291 Trial | OncLive
13:59
Capivasertib and Fulvestrant for Patients with Aromatase Inhibitor-resistant Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer: Results from the Phase III CAPItello-291 Trial | OncLive
Nov 28, 2023
onclive.com
Dr Advani on the Role of Capivasertib Plus Fulvestrant in HR /HER2– Breast Cancer | OncLive
Dr Advani on the Role of Capivasertib Plus Fulvestrant in HR /HER2– Breast Cancer | OncLive
Jan 23, 2024
onclive.com
The Role of Capivasertib in ER /HER- mBC | OncLive
The Role of Capivasertib in ER /HER- mBC | OncLive
Feb 13, 2023
onclive.com
NHS approves breakthrough breast cancer drug Capivasertib for use
1:36
NHS approves breakthrough breast cancer drug Capivasertib for use
1 year ago
MSNWION
4:13
CAPItello-291 Trial: Evaluating Capivasertib Plus Fulvestrant in Patients With HR , HER2- Advanced Breast Cancer | OncLive
Feb 9, 2024
onclive.com
Best Practices in Managing Patients on Capivasertib | OncLive
Nov 4, 2024
onclive.com
SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigating Capivasertib and Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
617 viewsDec 15, 2023
vumedi.com
ESMO 2024 Insights: CAPItello-290 Trial - Capivasertib Paclitaxel as 1L Treatment for mTNBC
169 viewsSep 24, 2024
vumedi.com
SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & Fulvestrant for Aromatase Inhibitor-Resistant HR /HER2- Advanced BC"
1.6K viewsJan 26, 2024
vumedi.com
1:51
'Capivasertib' shrinks tumours & slows cancer growth: NHS
1 year ago
MSNWION
Analysis of the Phase III CAPItello-281 Trial: Capivasertib plus Abiraterone in PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer - Daniel George
5 months ago
urotoday.com
Le capivasertib, médicament d'AstraZeneca contre le cancer du sein, obtient un examen prioritaire aux Etats-Unis
Jun 12, 2023
zonebourse.com
31:19
AMJ Podcast | Episode 4 - Capivasertib in the Clinic: Strategies to Manage Adverse Events
32 views4 months ago
VimeoEuropean Medical Group Ltd
0:15
$
Capivasertib Rotating 3d Molecule Molecular Structure Stock Footage Video (100% Royalty-free) 3497812941 | Shutterstock
May 8, 2024
shutterstock
3:35
Final results of PAKT: capivasertib and paclitaxel for TNBC
1.5K viewsAug 10, 2018
YouTubeVJOncology
19:50
Starting my new cancer treatment capivasertib
239 views3 months ago
YouTubeSara & Dustin
2:19
Landmark moment for treatment of advanced breast cancer
5K viewsDec 8, 2022
YouTubeThe Institute of Cancer Research, London
21:42
Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study
4.3K viewsFeb 22, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discu…
2:15
Capivasertib in Advanced Breast Cancer | NEJM
6K viewsJun 1, 2023
YouTubeNEJM Group
5:15
Breast Cancer Breakthrough: Capivasertib's Amazing Results
12.1K viewsApr 11, 2025
YouTubeDr Liz O'Riordan
14:02
Approval of Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer: Jason Mouabbi and Carlos Doti
1.4K viewsJan 15, 2024
YouTubeOncology Data Advisor
2:31
🚨New drug approved by the FDA for patients with hormone receptor positive/HER2- metastatic breast cancer who have mutations in AKT, PIK3CA or PTEN: Capivasertib (in combinatiob with fulvestrant). #breastcancer #metastaticbreastcancer #mbc #bcsm #breastcancerthriver #oncologist #cancerdoctor
23.1K viewsNov 17, 2023
TikTokdrteplinsky
1:25
ProCAID: capivasertib plus docetaxel and prednisolone chemotherapy for the treatment of mCRPC
273 viewsMar 1, 2022
YouTubeVJOncology
3:15
Mechanism of Action of JAK Inhibitors
147.8K viewsJun 6, 2017
YouTubeMechanisms in Medicine
7:53
Dana-Farber’s Updated Consensus Statement on Capivasertib + Fulvestrant for ER+ Breast Cancer
205 views7 months ago
YouTubeBreast Cancers Today
T-cell Transfer Therapy - Immunotherapy
Aug 5, 2024
cancer.gov
1:58
TRUQAP™ (capivasertib)- locally advanced or metastatic breast cancer
450 viewsMar 4, 2025
YouTubePharmacy Talk USA
See more